Erratum to: Interleukin-18 as a severity marker and novel potential therapeutic target for epidermolytic ichthyosis. . Clin Exp Dermatol 2023 Jan 19:llad006. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Erratum to: Interleukin-18 as a severity marker and novel potential therapeutic target for epidermolytic ichthyosis. Clin Exp Dermatol 2023 Jan 19:llad006. doi: 10.1093.
PMID: 36656053